195 related articles for article (PubMed ID: 24150823)
1. [Off-label use of alitretinoin].
Fritz K; Tiplica GS; Salavastru C; Onder M
Hautarzt; 2013 Oct; 64(10):748-51. PubMed ID: 24150823
[TBL] [Abstract][Full Text] [Related]
2. [Alitretinoin: a new treatment option for chronic refractory hand eczema].
Molin S; Ruzicka T
Hautarzt; 2008 Sep; 59(9):703-4, 706-9. PubMed ID: 18704345
[TBL] [Abstract][Full Text] [Related]
3. Nail improvement during alitretinoin treatment: three case reports and review of the literature.
Milanesi N; D'Erme AM; Gola M
Clin Exp Dermatol; 2015 Jul; 40(5):533-6. PubMed ID: 25682921
[TBL] [Abstract][Full Text] [Related]
4. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema.
Bissonnette R; Worm M; Gerlach B; Guenther L; Cambazard F; Ruzicka T; Maares J; Brown TC
Br J Dermatol; 2010 Feb; 162(2):420-6. PubMed ID: 19906075
[TBL] [Abstract][Full Text] [Related]
5. A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of alitretinoin (BAL4079) in the treatment of severe chronic hand eczema refractory to potent topical corticosteroid therapy.
Fowler JF; Graff O; Hamedani AG
J Drugs Dermatol; 2014 Oct; 13(10):1198-204. PubMed ID: 25607554
[TBL] [Abstract][Full Text] [Related]
6. Oral alitretinoin: a review of the clinical pharmacokinetics and pharmacodynamics.
Schmitt-Hoffmann AH; Roos B; Schoetzau A; Leese PT; Meyer I; van de Wetering J; Kovacs P
Expert Rev Clin Pharmacol; 2012 Jul; 5(4):373-88. PubMed ID: 22943117
[TBL] [Abstract][Full Text] [Related]
7. Alitretinoin and acitretin in severe chronic hand eczema; results from a retrospective daily practice study.
Politiek K; Christoffers WA; Coenraads PJ; Schuttelaar MA
Dermatol Ther; 2016 Sep; 29(5):364-371. PubMed ID: 27146260
[TBL] [Abstract][Full Text] [Related]
8. Everyday clinical experience of alitretinoin in the treatment of severe chronic hand eczema: seven case studies.
English J; Graham-Brown R; de Sica Chapman A; Alexandroff AB
Clin Exp Dermatol; 2011 Mar; 36 Suppl():1-2. PubMed ID: 21309810
[TBL] [Abstract][Full Text] [Related]
9. An open-label study assessing the safety and efficacy of alitretinoin in patients with severe chronic hand eczema unresponsive to topical corticosteroids.
Dirschka T; Reich K; Bissonnette R; Maares J; Brown T; Diepgen TL
Clin Exp Dermatol; 2011 Mar; 36(2):149-54. PubMed ID: 21070335
[TBL] [Abstract][Full Text] [Related]
10. Effects of alitretinoin on quality of life of patients having chronic hand eczema: an observational study.
Gola M; D'Erme AM; Milanesi N; Marmugi L
Dermatitis; 2013; 24(4):166-9. PubMed ID: 23857016
[TBL] [Abstract][Full Text] [Related]
11. [Response to treatment with oral alitretinoin in patients with chronic hand eczema that is refractory to treatment with potent topical corticosteroids: experience in 15 patients].
Aguayo-Leiva IR; Urrutia S; Jaén-Olasolo P
Actas Dermosifiliogr; 2011 Oct; 102(8):616-22. PubMed ID: 21354545
[TBL] [Abstract][Full Text] [Related]
12. Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal.
Rodgers M; Griffin S; Paulden M; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
Pharmacoeconomics; 2010; 28(5):351-62. PubMed ID: 20131924
[TBL] [Abstract][Full Text] [Related]
13. Alitretinoin for the treatment of severe chronic hand eczema.
Paulden M; Rodgers M; Griffin S; Slack R; Duffy S; Ingram JR; Woolacott N; Sculpher M
Health Technol Assess; 2010 May; 14 Suppl 1():39-46. PubMed ID: 20507802
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial.
Ruzicka T; Lynde CW; Jemec GB; Diepgen T; Berth-Jones J; Coenraads PJ; Kaszuba A; Bissonnette R; Varjonen E; Holló P; Cambazard F; Lahfa M; Elsner P; Nyberg F; Svensson A; Brown TC; Harsch M; Maares J
Br J Dermatol; 2008 Apr; 158(4):808-17. PubMed ID: 18294310
[TBL] [Abstract][Full Text] [Related]
15. Safety of alitretinoin for severe refractory chronic hand eczema: Clinical studies and postmarketing surveillance.
Morris M; Schifano L; Fong R; Graff O
J Dermatolog Treat; 2016; 27(1):54-8. PubMed ID: 25886084
[TBL] [Abstract][Full Text] [Related]
16. Real-world experience with alitretinoin in a community dermatology practice setting in patients with chronic hand dermatitis.
Ham K; Maini P; Gooderham MJ
J Cutan Med Surg; 2014 Oct; 18(5):332-6. PubMed ID: 25186994
[TBL] [Abstract][Full Text] [Related]
17. Alitretinoin: A Review in Severe Chronic Hand Eczema.
Blair HA; Scott LJ
Drugs; 2016 Sep; 76(13):1271-1279. PubMed ID: 27438290
[TBL] [Abstract][Full Text] [Related]
18. Can median nail dystrophy be an adverse effect of alitretinoin treatment?
Winther AH; Bygum A
Acta Derm Venereol; 2014 Nov; 94(6):719-20. PubMed ID: 24691846
[No Abstract] [Full Text] [Related]
19. Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment.
Oosterhaven JAF; Schuttelaar MLA
BMJ Open; 2018 Jul; 8(7):e020192. PubMed ID: 29997136
[TBL] [Abstract][Full Text] [Related]
20. Oral alitretinoin. Severe chronic hand eczema: this retinoid is too risky.
Prescrire Int; 2010 Apr; 19(106):62-3. PubMed ID: 20568484
[No Abstract] [Full Text] [Related]
[Next] [New Search]
